An examination of Gal-3's predictive utility for new-onset heart failure (HF) in the Framingham Heart Study (FHS) revealed that, in a fully adjusted model incorporating both BNP and Gal-3, there was a modest yet independent predictive value for the occurrence of new-onset HF [7,42]. The gene discussed is NPPB; the disease is heart failure.